Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 1

Research Article

Use of Chinese Medicine and Subsequent Surgery in Women with Uterine Fibroid: A Retrospective Cohort Study

Table 1

Comparison of socio-demographic factors and co-morbidities between Chinese medicine (CM) users and nonusers in patients with uterine fibroids.

CM Nonusers
CM Users
Total
valuea
% % %

Age, years <0.0001
 <20180.401100.901280.77
 20–292686.0211519.4114198.50
 30–39112025.2360329.4472328.3
 40–49239453.8564346.1803748.2
 ≥5065214.7173114.1238314.3
 Mean ± SD42.9 ± 8.2041.6 ± 8.8441.9 ± 8.69<0.0001
Income, US$ per month0.86
 <564.3117826.5327626.8445426.7
 564.3–656.586819.5243819.9330619.8
 656.6–779.6129329.0351428.7480728.8
 ≥779.7111325.0301024.6412324.7
Occupational status0.009
 White collar245455.1701557.3946956.8
 Blue collar150033.7401632.8551633.1
 Others49811.212029.83170010.2
Area <0.0001
 Northern Taiwan228851.4550545.0779346.7
 Central Taiwan60413.6235319.2295717.7
 Southern Taiwan136430.6385231.5521631.3
 Eastern Taiwan and offshore islands1964.405234.287194.31
Comorbidity
 Excessive menstruation78217.6271822.2350021.0<0.0001
 Iron-deficiency anemia47310.6154912.7202212.10.0004
 Dysmenorrhea55512.5257121.0312618.7<0.0001
 Infertility90.20940.771030.62<0.0001

aChi-square test and -test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.